Cryo-Cell International, Inc. (CCEL) analyst actions
Rating and price-target actions on CCEL in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the CCEL overview →
1 measured CCEL analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend | Press release | +10.08% | +20.83% |
Keep exploring
More CCEL: earnings → · SEC filings → · CCEL overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| SWEDISH ORPHAN ADR (SWTUY) | 86 | 0.00% | 8% |
| BIOLASE INC (BIOL) | 85 | -2.09% | 28% |
| Kane Biotech Inc (KNE_CDNX) | 85 | 0.00% | 22% |
| Regen Biopharma, Inc. Common (RGBP) | 85 | 0.00% | 36% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.